Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients
Guthmann, Marcelo D, Castro, Mónica A, Cinat, Gabriela, Venier, Cecilia, Koliren, Leonardo, Bitton, Roberto J, Vázquez, Ana María, Fainboim, Leonardo
Published in Journal of immunotherapy (1997) (01.03.2006)
Published in Journal of immunotherapy (1997) (01.03.2006)
Get more information
Journal Article
Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity
Guthmann, Marcelo D, Bitton, Roberto J, Carnero, Ariel J L, Gabri, Mariano R, Cinat, Gabriela, Koliren, Leonardo, Lewi, Daniel, Fernandez, Luis Enrique, Alonso, Daniel F, Gómez, Daniel E, Fainboim, Leonardo
Published in Journal of immunotherapy (1997) (01.11.2004)
Published in Journal of immunotherapy (1997) (01.11.2004)
Get more information
Journal Article
Cancer vaccines: an update with special focus on ganglioside antigens
Bitton, Roberto J, Guthmann, Marcel D, Gabri, Mariano R, Carnero, Ariel J L, Alonso, Daniel F, Fainboim, Leonardo, Gomez, Daniel E
Published in Oncology reports (01.03.2002)
Published in Oncology reports (01.03.2002)
Get more information
Journal Article
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin
Bitton, R J, Figg, W D, Venzon, D J, Dalakas, M C, Bowden, C, Headlee, D, Reed, E, Myers, C E, Cooper, M R
Published in Journal of clinical oncology (01.09.1995)
Published in Journal of clinical oncology (01.09.1995)
Get more information
Journal Article
A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response
Bowden, C J, Figg, W D, Dawson, N A, Sartor, O, Bitton, R J, Weinberger, M S, Headlee, D, Reed, E, Myers, C E, Cooper, M R
Published in Cancer chemotherapy and pharmacology (1996)
Published in Cancer chemotherapy and pharmacology (1996)
Get more information
Journal Article